litlas
Log inCreate account

Emma Guttman‐Yassky

Active 2006–2025

Also published as
Emma Guttman-Yassky · Emma Guttman Yassky
318
Papers
43,638
Citations
117
h-index
293
i10-index

Citations

Citations per year for Emma Guttman‐Yassky1986: 6 citations1997: 1 citations2003: 3 citations2005: 1 citations2007: 8 citations2008: 10 citations2009: 45 citations2010: 97 citations2011: 143 citations2012: 110 citations2013: 138 citations2014: 204 citations2015: 279 citations2016: 334 citations2017: 506 citations2018: 609 citations2019: 1,876 citations2020: 2,210 citations2021: 2,733 citations2022: 2,274 citations2023: 2,565 citations2024: 3,358 citations2025: 1,934 citations2026: 28 citations1987–1996: no citations, so these years are not shown1998–2002: no citations, so these years are not shown2004: no citations, so this year is not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,869 citing papers, 21.5% of this breakdownChina: 1,186 citing papers, 8.9% of this breakdownGermany: 982 citing papers, 7.3% of this breakdownUnited Kingdom: 766 citing papers, 5.7% of this breakdownItaly: 664 citing papers, 5% of this breakdownJapan: 641 citing papers, 4.8% of this breakdownCanada: 507 citing papers, 3.8% of this breakdownFrance: 500 citing papers, 3.7% of this breakdownSwitzerland: 422 citing papers, 3.1% of this breakdownSpain: 397 citing papers, 3% of this breakdownNetherlands: 384 citing papers, 2.9% of this breakdownSouth Korea: 337 citing papers, 2.5% of this breakdown
0%21.5%Other 27.8%

Institutions

Fields

  • Medicine72.6%
  • Immunology and Microbiology16.9%
  • Biochemistry, Genetics and Molecular Biology6.8%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.6%
  • Agricultural and Biological Sciences0.3%
  • Other1.9%

Topics

  • Dermatology and Skin Diseases19.4%
  • Allergic Rhinitis and Sensitization8.2%
  • Psoriasis: Treatment and Pathogenesis8.2%
  • Asthma and respiratory diseases7.6%
  • Urticaria and Related Conditions3.2%
  • Food Allergy and Anaphylaxis Research3%
  • Other50.4%

Coauthors

All papers

Open in search
  1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Authors: Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - New England Journal of Medicine 2016 cited by 2,045

  2. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    Authors: Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky, Margitta Worm, Charles Lynde, J.‐P. Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Yves Poulin, Aleksandra Lesiak, Leon Kircik, S.H. Cho, Pedro Herranz, Michael J. Cork, Ketty Peris, Louise Abildgaard Steffensen, B K Bang, Alexandra Kuznetsova, T.N. Jensen, Marie Louise Østerdal, Eric L. Simpson, the ECZTRA 1 and ECZTRA 2 study investigators - British Journal of Dermatology 2020 cited by 595

  3. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

    Authors: Emma Guttman‐Yassky, Henrique D. Teixeira, Eric L. Simpson, Kim Papp, Aileen L. Pangan, Andrew Blauvelt, Diamant Thaçi, Chia‐Yu Chu, Hyuck-Ki Hong, Norito Katoh, Amy S. Paller, Brian Calimlim, Yihua Gu, Xiaofei Hu, Meng Liu, Yang Yang, John Liu, Allan R. Tenorio, Alvina D. Chu, Alan D. Irvine - The Lancet 2021 cited by 543

  4. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

    Authors: Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar, Mayte Suárez‐Fariñas, Marius Ardeleanu, Hitokazu Esaki, Maria Suprun, Yeriel Estrada, Hui Xu, Xiangyu Peng, Jonathan I. Silverberg, Alan Menter, James G. Krueger, Rick Zhang, Usman Chaudhry, Brian N. Swanson, Neil M.H. Graham, Gianluca Pirozzi, George D. Yancopoulos, Jennifer D. Hamilton - Journal of Allergy and Clinical Immunology 2018 cited by 678

  5. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

    Authors: Jonathan I. Silverberg, Emma Guttman‐Yassky, Diamant Thaçi, Alan D. Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L. Simpson, Chia‐Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar Pillai, Julien Sénéschal - New England Journal of Medicine 2023 cited by 314

  6. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis

    Authors: Helen He, Hemant Suryawanshi, Pavel Morozov, Jesús Gay-Mimbrera, Ester Del Duca, Hyun Je Kim, Naoya Kameyama, Yeriel Estrada, Evan Der, James G. Krueger, Juan Ruano, Thomas Tuschl, Emma Guttman‐Yassky - Journal of Allergy and Clinical Immunology 2020 cited by 508

  7. Type 2 immunity in the skin and lungs

    Authors: Cezmi A. Akdiş, Peter D. Arkwright, Marie‐Charlotte Brüggen, William W. Busse, Massimo Gadina, Emma Guttman‐Yassky, Kenji Kabashima, Yasutaka Mitamura, Laura Vian, Jianni Wu, Óscar Palomares - Allergy 2020 cited by 552

  8. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

    Authors: Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Mark Boguniewicz, Lawrence Sher, Melinda Gooderham, Lisa A. Beck, Emma Guttman‐Yassky, David M. Pariser, Andrew Blauvelt, Jamie Weisman, Benjamin Lockshin, Thomas Hultsch, Qin Zhang, Mohamed Kamal, John D. Davis, Bolanle Akinlade, Heribert Staudinger, Jennifer D. Hamilton, Neil M.H. Graham, Gianluca Pirozzi, Abhijit Gadkari, Laurent Eckert, Neil Stahl, George D. Yancopoulos, Marcella Ruddy, Ashish Bansal - JAMA Dermatology 2019 cited by 509

  9. Atopic dermatitis endotypes and implications for targeted therapeutics

    Authors: Tali Czarnowicki, Helen He, James G. Krueger, Emma Guttman‐Yassky - Journal of Allergy and Clinical Immunology 2019 cited by 611

  10. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

    Authors: Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, Melissa Hager, Neil Stahl, George D. Yancopoulos, Allen Radin - New England Journal of Medicine 2014 cited by 1,405

  11. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

    Authors: Julia Gittler, Avner Shemer, Mayte Suárez‐Fariñas, Judilyn Fuentes‐Duculan, Kara J. Gulewicz, Claire Q. Wang, Hiroshi Mitsui, Irma Cardinale, Cristina de Guzman Strong, James G. Krueger, Emma Guttman‐Yassky - Journal of Allergy and Clinical Immunology 2012 cited by 958

  12. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

    Authors: Marek Jutel, Ioana Agache, Magdalena Zemelka‐Wiącek, Mübeccel Akdiş, Tomás Chivato, Stefano Del Giacco, Paweł Gajdanowicz, Ibon Eguíluz‐Gracia, Ludger Klimek, Antti Lauerma, Markus Ollert, Liam O’Mahony, Jürgen Schwarze, Mohamed H. Shamji, Isabel Skypala, Óscar Palomares, Oliver Pfaar, Marı́a José Torres, Jonathan A. Bernstein, Álvaro A. Cruz, Stephen R. Durham, Stephen J. Galli, René Maximiliano Gómez, Emma Guttman‐Yassky, Tari Haahtela, Stephen T. Holgate, Kenji Izuhara, Kenji Kabashima, Désirée Larenas‐Linnemann, Erica von Mutius, Kari C. Nadeau, Ruby Pawankar, Tomas A. E. Platts‐Mills, Scott H. Sicherer, Hae‐Sim Park, Stefan Vieths, Gary Wong, Luo Zhang, Maria Beatrice Bilò, Cezmi A. Akdiş - Allergy 2023 cited by 256

  13. The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment

    Authors: Paola Facheris, Jane Jeffery, Ester Del Duca, Emma Guttman‐Yassky - Cellular and Molecular Immunology 2023 cited by 219

  14. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies

    Authors: Patrick M. Brunner, Emma Guttman‐Yassky, Donald Y.M. Leung - Journal of Allergy and Clinical Immunology 2017 cited by 626

  15. Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

    Authors: Yael Renert‐Yuval, Jacob P. Thyssen, Robert Bissonnette, Thomas Bieber, Kenji Kabashima, DirkJan Hijnen, Emma Guttman‐Yassky - Journal of Allergy and Clinical Immunology 2021 cited by 326

  16. An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study

    Authors: Emma Guttman‐Yassky, Eric L. Simpson, Kristian Reich, Kenji Kabashima, Ken Igawa, Tetsuya Suzuki, Hirotaka Mano, Takeshi Matsui, Ehsanollah Esfandiari, Masutaka Furue - The Lancet 2022 cited by 174

  17. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

    Authors: Gerd R Burmester, Stanley Cohen, Kevin Winthrop, Peter Nash, Alan D. Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P. Lacerda, Hannah Palac, Tim Shaw, Philip J. Mease, Emma Guttman‐Yassky - RMD Open 2023 cited by 210

  18. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs

    Authors: Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, Claus Bachert, Thomas Bieber, Giorgio Walter Canonica, Emma Guttman‐Yassky, Martin Metz, Joaquim Mullol, Óscar Palomares, Harald Renz, Sonja Ständer, Torsten Zuberbier, Marcus Maurer - Nature Reviews Drug Discovery 2023 cited by 146

  19. Obesity alters pathology and treatment response in inflammatory disease

    Authors: Sagar P. Bapat, Caroline Whitty, Cody T. Mowery, Yuqiong Liang, Arum Yoo, Zewen Jiang, Michael C. Peters, Ling‐juan Zhang, Ian Vogel, Carmen Zhou, Vinh Nguyen, Zhongmei Li, Christina C. Chang, Wandi S. Zhu, Annette T. Hastie, Helen He, Xin Ren, Wenli Qiu, Sarah G. Gayer, Chang Liu, Eun Jung Choi, Marlys S. Fassett, Jarish N. Cohen, Jamie Sturgill, Laura E. Crotty Alexander, Jae Myoung Suh, Christopher Liddle, Annette R. Atkins, Ruth T. Yu, Michael Downes, Sihao Liu, Barbara S. Nikolajczyk, In-Kyu Lee, Emma Guttman‐Yassky, K. Mark Ansel, Prescott G. Woodruff, John V. Fahy, Dean Sheppard, Richard L. Gallo, Chun Ye, Ronald M. Evans, Ye Zheng, Alexander Marson - Nature 2022 cited by 243

  20. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

    Authors: Shinji Noda, Mayte Suárez‐Fariñas, Benjamin Ungar, Soo Jung Kim, Cristina de Guzman Strong, Hui Xu, Xiangyu Peng, Yeriel Estrada, Saeko Nakajima, Tetsuya Honda, Jung U Shin, Hemin Lee, James G. Krueger, Kwang-Hoon Lee, Kenji Kabashima, Emma Guttman‐Yassky - Journal of Allergy and Clinical Immunology 2015 cited by 647

  21. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

    Authors: Anne‐Sofie Halling, Nikolai Loft, Jonathan I. Silverberg, Emma Guttman‐Yassky, Jacob P. Thyssen - Journal of the American Academy of Dermatology 2020 cited by 278

  22. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials

    Authors: Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman‐Yassky, Thomas Bieber, E. Serra‐Baldrich, Eric L. Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther García Gil, Jonathan I. Silverberg - British Journal of Dermatology 2023 cited by 149

  23. Conjunctivitis in dupilumab clinical trials

    Authors: Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller, Eric L. Simpson, Andrew Blauvelt, Michael J. Cork, Errol P. Prens, Penny A. Asbell, Esen K. Akpek, Jonathan Corren, Claus Bachert, Ikuo Hirano, Jonathan Weyne, Andrew Korotzer, Z. Chen, Thomas Hultsch, Xiaoping Zhu, John D. Davis, Leda Mannent, Jennifer D. Hamilton, Ariel Teper, Heribert Staudinger, E. Rizova, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel, Marius Ardeleanu, Andreas Wollenberg - British Journal of Dermatology 2019 cited by 422

  24. Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

    Authors: Emma Guttman‐Yassky, Diamant Thaçi, Aileen L. Pangan, Hwanhee Hong, Kim Papp, Kristian Reich, Lisa A. Beck, Mohamed‐Eslam F. Mohamed, Ahmed A. Othman, J. Anderson, Yihua Gu, Henrique D. Teixeira, Jonathan I. Silverberg - Journal of Allergy and Clinical Immunology 2019 cited by 357